Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA.
Mol Genet Metab. 2010;99 Suppl 1:S96-9. doi: 10.1016/j.ymgme.2009.10.006.
Cognitive deficits, learning difficulties, and emotional problems occur at significantly higher rates in individuals with phenylketonuria (PKU) than in the general population. The relationship between elevated blood phenylalanine (Phe) levels and the severity of these problems often remain unrecognized. Children and adults with PKU require ongoing screening so that referrals to psychologists or psychiatrists familiar with metabolic disorders can be made when necessary for in-depth evaluation and treatment. To identify screening instruments that can be used by non-psychologists as well as psychologists, a group of 10 psychologists and a psychiatrist in the United States with expertise in neuropsychological assessment and PKU proposed a Uniform Assessment Method for PKU. Questionnaires were selected that reliably detect problems in adaptive behavior, executive function, and emotional well-being, representing the most vulnerable areas for individuals with PKU. These questionnaires are appropriate for individuals from infancy through adulthood, may be administered in less than 1h, have computerized scoring accessibility, have no practice effects, and are available in Spanish and English. In addition to assessing function at a single point in time, the screening measures may be administered at each clinic visit to assess changes in function related to metabolic status or treatment (e.g., Phe-restricted diet, food supplements). The following questionnaires comprise the Uniform Assessment Method for PKU: for 0-2 years, Adaptive Behavior Assessment System-Second Edition (ABAS-II); for 2-17 years, Behavior Rating Inventory of Executive Function (BRIEF) and Behavior Assessment System for Children-Second Edition (BASC-II); and for adults, BRIEF, Beck Anxiety Inventory (BAI), and Beck Depression Inventory-Second Edition (BDI-II). In addition to long-term monitoring of outcomes in PKU, this uniform screening approach facilitates PKU research, as data may be pooled across multiple clinics using a consistent battery of assessment measures.
认知障碍、学习困难和情绪问题在苯丙酮尿症(PKU)患者中的发生率明显高于普通人群。升高的血液苯丙氨酸(Phe)水平与这些问题的严重程度之间的关系往往未被认识到。PKU 患儿和成人需要进行持续的筛查,以便在必要时转介给熟悉代谢紊乱的心理学家或精神科医生进行深入评估和治疗。为了确定可以由非心理学家和心理学家使用的筛查工具,美国的一组 10 名心理学家和一名精神病学家,他们在神经心理学评估和 PKU 方面具有专业知识,提出了 PKU 的统一评估方法。选择了可靠地检测适应行为、执行功能和情绪健康问题的问卷,这些问题代表了 PKU 患者最脆弱的领域。这些问卷适用于从婴儿期到成年期的个体,可以在不到 1 小时内完成,具有计算机评分功能,没有练习效果,并且有西班牙语和英语两种版本。除了评估个体在某个时间点的功能外,这些筛查工具还可以在每次就诊时进行评估,以评估与代谢状态或治疗相关的功能变化(例如,限制苯丙氨酸的饮食、食物补充剂)。该统一评估方法包括以下问卷:0-2 岁使用适应性行为评估系统第二版(ABAS-II);2-17 岁使用执行功能行为评定量表(BRIEF)和儿童行为评定系统第二版(BASC-II);18 岁及以上使用 BRIEF、贝克焦虑量表(BAI)和贝克抑郁量表第二版(BDI-II)。除了长期监测 PKU 的结果外,这种统一的筛查方法还促进了 PKU 的研究,因为可以使用一致的评估工具包在多个诊所中汇总数据。